SKG-0702

N/A

Report date: 2025/06/11 10:53:43

Base Information

Drug NameSKG-0702
Drug Alias NameATP7b gene therapy (Skyline therapeutics)
ClassificationCell and gene therapy > Gene therapy > Viral vector-based gene therapy > Adeno-associated virus vector
Mechanisms of ActionCopper-transporting ATPase 2 modulators
TargetsCopper-transporting ATPase 2
Therapy Area/IndicationsHepatolenticular Degeneration
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesSkyline Therapeutics (US) Inc
China Registration ClassN/A

Develop Information

Active CompaniesSkyline Therapeutics (US) Inc
Inactive CompaniesN/A
Active IndicationsHepatolenticular Degeneration
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A